Loading clinical trials...
Loading clinical trials...
Encore PFO Closure Device U.S. IDE Randomized Trial - The PerFOrm Trial
Conditions
Interventions
Encore PFO closure device
FDA-approved PFO closure device
Locations
8
United States
Arkansas Cardiology
Little Rock, Arkansas, United States
Southern CA Permanente Medical Group - Kaiser San Diego and Scripps Memorial Hospital
La Jolla, California, United States
University of South Florida
Tampa, Florida, United States
Mercy One Iowa Heart Center
West Des Moines, Iowa, United States
Kansas University Medical Center
Kansas City, Kansas, United States
Jackson Heart Clinic
Jackson, Mississippi, United States
Start Date
July 12, 2023
Primary Completion Date
April 1, 2026
Completion Date
October 1, 2030
Last Updated
September 19, 2024
NCT07172464
NCT07420400
NCT06590467
NCT07170176
NCT06203873
NCT04075084
Lead Sponsor
Encore Medical Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions